WEISSMAN JAMES B (Chief Business Officer) sold 65.2% of their position (30K shares) of DICERNA PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.17M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2021ACC: 0001399529-21-000132
Officer· Chief Business Officer
Since Aug 2018
-30K
Net shares
Net seller
$1.17M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
$9.09
Trade value
$272.70K
% of position
187.5%
7/6/2021
16K→46K
Common Stock
Direct
Shares
−30K
Price / share
$39.09
Trade value
$1.17M
% of position
65.2%
7/6/2021
46K→16K
Total
Net shares
+0.00
Net value
-$900K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2021 | M · Option Exercise | +30K | $9.09 | $272.70K | 187.5% | 16K | 46K |
| Common Stock Direct | 7/6/2021 | S · Sale | −30K | $39.09 | $1.17M | 65.2% | 46K | 16K |
| Total | +0.00 | -$900K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
9.09
Held after
34K
Exercisable
—
7/6/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock30K shares | 7/6/2021 | M · Option Exercise | −30K | 9.09 | — | 34K |